North America Anatomic Pathology Track and Trace Solutions Market - Market Share Analysis, Industry Trends & Statistics, and Growth Forecasts 2020 - 2035
The North America Anatomic Pathology Track and Trace Solutions Market is expected to witness substantial growth driven by advancements in automation and regulatory requirements for specimen safety. The market size was valued at USD 480 Million in 2025 and is anticipated to reach USD 1,520 Million by 2035, expanding at a CAGR of 11.3% from 2024 to 2035.
The economic impact of tariffs on "North America Anatomic Pathology Track and Trace Solutions Market".
Market Growth Drivers
Increasing regulatory mandates for specimen traceability and patient safety is a primary growth driver. Organizations such as the College of American Pathologists (CAP) require strict compliance for tracking biospecimens, compelling labs to integrate advanced track and trace solutions. Companies like Thermo Fisher Scientific have expanded their pathology software solutions to support end-to-end specimen tracking, ensuring accurate chain-of-custody and reducing sample mix-ups.
Growing adoption of digital pathology and laboratory automation is fueling demand for integrated track and trace systems. Hospitals and diagnostic centers are investing in technologies to streamline workflows, minimize errors, and achieve operational efficiency. For example, Leica Biosystems introduced workflow automation and digital tracking tools that are widely implemented in American pathology labs, resulting in improved turnaround time and enhanced patient care.
Market Trends
Integration of Artificial Intelligence (AI) with track and trace solutions is an emerging trend in the market. AI-powered platforms are enhancing the accuracy of specimen identification and tracking, enabling predictive analytics for lab logistics. Recent collaborations, such as the partnership between Roche and PathAI, aim to fuse AI with pathology specimen management to optimize tracking and diagnostic accuracy.
Expansion of cloud-based pathology tracking platforms is also shaping the market's trajectory. Cloud solutions offer laboratories scalable infrastructure, enhanced data accessibility, and robust compliance with HIPAA and other security standards. Ventana Medical Systems, for instance, rolled out cloud-enabled tracking modules allowing multi-site labs to monitor specimen status in real-time and maintain seamless data integration.
Market Opportunity
The growing prevalence of cancer and chronic diseases in North America presents opportunities for pathology labs to upgrade to advanced track and trace solutions, supporting increased specimen volumes and complex diagnostic workflows. Companies providing scalable and interoperable systems stand to capture significant market share, such as Cerner Corporation expanding its digital pathology and tracking capabilities.
The rise in precision medicine initiatives offers market players opportunities to collaborate with pharmaceutical firms and research institutions, integrating pathology tracking with bio-banking and clinical trial workflows to enhance sample integrity and data accuracy.
North America Anatomic Pathology Track and Trace Solutions Market Revenue (USD Million), 2020-2035
The chart illustrates the projected growth of the North America Anatomic Pathology Track and Trace Solutions Market from 2020 to 2035. The revenue demonstrates a consistent upward trend, beginning at USD 255 Million in 2020 and rising to USD 1,520 Million by 2035. The market experiences steady growth in the early years but accelerates sharply post-2028, reflecting increased adoption of advanced solutions and regulatory-driven investments. The CAGR of 11.3% underscores robust momentum, with higher revenue jumps observed in the 2030s as digital transformation intensifies across healthcare labs.
North America Anatomic Pathology Track and Trace Solutions Market by Region (%), 2025
The 2025 regional market share pie chart reveals that the United States dominates the North America Anatomic Pathology Track and Trace Solutions Market, accounting for 74% share, primarily due to higher adoption of advanced pathology technologies and strict regulatory norms. Canada holds the second-largest share at 17%, benefitting from national digitization efforts in healthcare. Mexico, with 6%, is gradually increasing its presence as hospitals modernize laboratory networks. The 'Rest of North America' and 'Other Territories' collectively make up 3%. The distribution underscores the market's concentration in developed healthcare systems with ongoing digital pathology adoption.
Recent Developments in the Market
In March 2024, LabCorp announced the rollout of its next-generation specimen tracking system across its North American labs, enhancing real-time visibility and error reduction. The system, implemented in collaboration with Zebra Technologies, utilizes advanced barcoding and RFID integration, delivering improved sample integrity and chain-of-custody compliance.
In May 2024, Roche Diagnostics introduced its cloud-based Digital Pathology Network, supporting multi-site anatomic pathology labs across the United States. The platform leverages AI-driven analytics and integrated track-and-trace features, reportedly reducing specimen location errors by 35%. Major teaching hospitals partnered for pilot deployment.
In February 2024, Leica Biosystems upgraded its Pathology Workflow Suite with AI-enhanced specimen tracking modules. The upgrade offers predictive alerts, real-time temperature monitoring for sensitive biospecimens, and integrative dashboards, streamlining compliance reporting and patient safety assurance for over 50 U.S. hospital networks.
Press Releases